At a glance
The following data are estimates about vaccine confidence among adults 18 years and older. This includes COVID-19, flu, and RSV vaccination concerns, issues, and motivators. These estimates can be used to understand information gaps and develop messages to support informed decision-making.
Data Summary
Surveys are conducted online using Ipsos KnowledgePanel and the NORC AmeriSpeak probability-based panels. Data are based on responses from adults 18 years and older regarding COVID-19, flu, and RSV vaccination concerns, issues, and motivators. Estimates are updated every 2 months. Updates to concerns and issues data alternate publishing months with the motivators data.
Concerns and Issues
- For August 2025, the most commonly reported vaccination concern or issue among adults 18 years and older was "possible serious or unknown side effects" for COVID-19 vaccine (34.9%) and "not concerned about getting the flu" for flu vaccine (21.0%). This was consistent across most demographic subgroups but varied by intent to get vaccinated.
- Among adults 50-74 years with high-risk condition(s) and adults 75 years and older, the most commonly reported concerns/issues about RSV vaccination were "do not know enough about RSV or the vaccine" (19.8%), "no provider recommendation" (18.8%), and "possible serious or unknown side effects" (18.6%). This was consistent across most demographic subgroups but varied by intent to get vaccinated.
- Many adults reported no concerns or issues about these vaccines (28.0% for COVID-19; 48.1% for flu; 50.1% for RSV).
Motivators
- For September 2025, the most commonly reported vaccination motivator among adults 18 years and older was "to protect myself" for COVID-19 (41.5%), flu (47.4%), and RSV (56.0%) vaccines. This was largely consistent across demographic subgroups but varied by intent to get vaccinated.
- Some adults reported nothing would motivate them to get these vaccines (30.7% for COVID-19; 27.3% for flu; 18.1% for RSV).